Background: Cancer is a complex health problem requiring multidisciplinary care. There are clinical guidelines available in order to improve the process and outcomes of cancer care within Europe. However, strategic action is still needed in many European Union (EU) Member States to develop or improve national cancer control plans (NCCPs), which play a key role in cancer control and care. The current study clarifies the extent of implementation of psychosocial oncology care (PSOC) in the EU.
Introduction
Psychological morbidity has known negative consequences for cancer patient quality of life and clinical outcomes. Several studies indicate it may decrease treatment compliance [1] and chemotherapy effectiveness [2] , and shorten survival time [3, 4] . It may also increase symptom burden and functional impairment [5] , resulting in longer hospital stays [6] and increased suicide risk [7] . To achieve the best clinical outcomes for cancer patients, it is important to consider patients' psychosocial needs and include these in a comprehensive treatment plan. Quality cancer care nowadays recommends that patients' psychosocial needs be regularly assessed and that psychosocial oncology services and mental health specialists are available to address those needs as an integral part of quality comprehensive cancer care [8] [9] [10] .
Towards the attainment of the highest standards of health and quality of life for cancer patients, the International Psycho-oncology Society (IPOS) has codified a global standard, which was recently updated to state the following [11] :
1. Psychosocial cancer care should be recognized as a universal human right. 2. Quality cancer care must integrate the psychosocial domain into routine care. 3. Distress should be measured as the sixth vital sign after temperature, blood pressure, pulse, respiratory rate and pain.
Psychosocial oncology care (PSOC) provides interventions aimed at ameliorating or reducing the impact of cancer on mental health and at improving patients' skills to cope with the demands of treatment and uncertainty of the disease outcome across the whole spectrum from pre-diagnosis to palliative care and survivorship. Evidence on efficacy of psychosocial interventions is well established [12] [13] [14] [15] and indicates that providing PSOC to patients and their families as part of standard care reduces distress and psychosocial morbidity and improves quality of life and well-being during and after cancer treatment. More recent data indicate cost-effect/cost-offset benefits to cancer care systems of delivery where PSOC is provided [16, 17] .
There are currently a number of clinical practice guidelines on distress management and PSOC that provide direction for effective evidence-based practice [18] [19] [20] [21] [22] . Dissemination and use of clinical guidelines are also important for quality assurance. Despite PSOC being considered an important part of comprehensive cancer care, there is some evidence that psychosocial needs of patients continue to be under-diagnosed and these services may not be routinely available to patients as part of routine comprehensive cancer care, from disease diagnosis, across treatment phases and survivorship [10, 23, 24] . Provision of PSOC services in Europe is very diverse and irregular and greatly depends on the extent to which a country and its national cancer control plan (NCCP) or strategy considers it a priority. PSOC services have been reported to be available mostly in cancer centres, university hospitals and oncological rehabilitation centres across Europe, but more rarely in general hospitals [25] . Reuben [24] in 2004 also reported that referrals to these services and/or community support groups were inconsistent, and in some countries, their availability was scarce or absent.
At present, there is a lack of precise evidence on the implementation of PSOC within national healthcare systems, and research is needed to clarify availability in different healthcare provision areas of cancer (i.e. inpatient and outpatient services, rehabilitation, prevention and palliative care) [26] . An analysis of European NCCPs conducted in 2009 showed that only 19 of 31 countries 1 had an NCCP and specified palliative care and rehabilitation within their targets [27] . Of these, only 16 countries 2 mentioned psychosocial oncology support in the cancer plan and included it in rehabilitation care, and only seven countries 3 referred to the need for improvement of PSOC and had a method for evaluating the plan, its objectives and outcomes, thus ensuring control for its provision. A survey carried out in 2012 with the report from the IPOS federated national psycho-oncology societies indicated that PSOC was an integral part of cancer care in a minority of European Union (EU) countries [28] .
Availability of, and access to, trained professionals in psycho-oncology is another important issue. In all European countries, only 16 out of 51 have a federated national psycho-oncology society, 4 which likely impacts availability of specialized professionals within those countries and their interest in fostering psychosocial oncology [28] . However, we know neither the existing training resources in PSOC and in communication skills in European countries nor their needs. Good communication skills are the first level of psychosocial care to be provided by all clinical staff [18] . As such, it is also important that this training be available for healthcare professionals, as part of PSOC.
European Partnership for Action Against Cancer
In September 2009, the European Commission launched the European Partnership for Action Against Cancer (EPAAC) to support Member States and stakeholders in their efforts to tackle cancer more efficiently by providing a framework for identifying and sharing information, best practices, capacity and expertise in cancer prevention, control and care. The main aim of the Partnership is for all Member States to have integrated cancer plans and to reduce cancer by 15% in 2020. This consortium of Member States, scientific societies, patients' organizations and stakeholders have agreed to collaborate, as either associated or collaborating partners, under the umbrella of EPAAC, and develop an EU-funded Joint Action (JA) project. The JA project of the EPAAC includes specific measures to tackle the major areas of cancer control and care across countries, including PSOC, with the aim to improve understanding and provision of PSOC in Europe, reducing inequalities and improving cancer care for all. This JA targets five main areas in cancer: prevention, screening, health care, research and data information. The healthcare work package (WP7) (http://www.epaac. eu/healthcare) generally intends to identify, assess and exchange best practices in cancer care across Europe and integrates diverse objectives and deliverables, namely, a Psychosocial Oncology Action. The Psychosocial Oncology Action aims to implement a training strategy to improve psychosocial care in Europe [29] .
Information in Europe is missing on how psychosocial care is provided and organized. Previous studies have focused on (a) a global perspective from professionals' point of view and a small sample, which does not cover specifically Europe [24, 25, 28] , and (b) European NCCPs analysis, which does not cover how psychosocial care is provided [27] .
The main aim of the present study is to fill this gap by conducting a mapping of resources and needs in PSOC in European countries, from an official perspective provided by each country's Ministry of Health. It is expected that the evidence will contribute to a better understanding of psychosocial resources across Europe and promote capacity building for better provision in this area.
Method

Participants
All the Member State officers for the Ministries of Health of the 30 European countries included in EPAAC (EU plus three of the European Economic Area) (www.epaac.eu) were asked to complete the survey questionnaire. These Members State officers, one per country, were nominated as representatives of their country by their Ministries of Health for participating in EPAAC. Questionnaires were emailed to each participant in October 2012, and various reminders sent until March 2013. Replies were sent either by the Member State officer or from an appointed national specialist in psycho-oncology, or from a national oncology or public health department.
Measure
We designed a short and easy-to-answer questionnaire to assess the PSOC profile of resources of each country within their National Health Service (NHS) (see supplemental appendix, available online as Supporting information), based on previous research on psycho-oncology resources in the Portuguese National Health Service [30] . Four dimensions of inquiry were addressed by the questionnaire:
1. inclusion of PSOC in NCCP, budget allocated and how psychosocial care is provided; 2. structure and resources of psychosocial care delivery; 3. use of clinical guidelines; and 4. education, training resources and needs in PSOC.
We also asked for the participants' comments on the main difficulties, barriers or constraints to implementing psychosocial cancer care.
Owing to the characteristics of the survey, analysis of the data was purely descriptive, without statistical analysis. Percentages are rounded off. Concerning the comments on the main difficulties, barriers or constraints to implementing psychosocial cancer care, we have listed all the barriers as reported by the participants.
Results
Of the 30 European countries contacted to participate in this survey, 27 replied to the questionnaire 5 (90%). The present analysis reports results from these countries of which only Norway is not an EU member. For the purpose of this study, we intended to obtain a mapping of European resources and needs in PSOC. As such, in this analysis, we have focused on the quantitative data obtained for each of the four dimensions for the 27 countries taken as a whole, without specifying the situation of each country.
Inclusion of PSOC in national cancer strategy or NCCP
Psychosocial oncology care is included in the NCCP in 21 (78%) countries and of these, only 10 (37%) have specific budgets allocated for PSOC. In terms of financial responsibility for provision of PSOC, most countries indicated that there were several sources; however, most were not from national or regional healthcare budgets. The resource providers most mentioned as supplying some cost contributions were as follows: local/hospital budget (n = 16; 59%), charities/non-governmental organizations (n = 16; 59%) and cancer patients' organizations (n = 15; 55%), followed by national (Ministry of Health responsibility) (n = 11; 41%) and regional organizations (regions administrative responsibility) (n = 10; 37%) ( Figure 1 ).
Structure and resources of PSOC delivery
The questionnaire asked for details on where PSOC is most likely to be provided (1 = most likely; 9 = least likely). Some countries identified not one but several institutions as most likely. Considering only the institutions classified as 'most likely', PSOC is most likely to be available and delivered in cancer centres (21; 78%), university hospitals (11; 41%) and general hospitals (10; 37%) ( Figure 2 ). Other local providers mentioned were as follows: rehabilitation centres (five; 19%), charities or non-governmental organizations (five; 19%), primary care facilities (four; 15%), cancer patient organizations (five; 19%) and community services (seven; 40%).
In terms of who are the PSOC providers, and considering the answers rated as 'most likely', 19 countries (70%) rated the psychologist as the professional most likely to be providing PSOC; for 10 countries (37%), nurses were rated as the most likely; in seven (26%), social workers; in six (22%), physicians; in five (19%), pastors, priests or hospital chaplains; in four (15%), qualified counsellors; in four (15%), volunteers; and finally, in three (11%) countries, psychiatrists. Many countries identified more than one category of professional as the 'most likely' provider of PSOC.
In terms of the number of psychosocial cancer care specialists working in cancer facilities under NHS responsibility in each country, most of the countries were not able to provide us with any data.
Use of clinical guidelines for psychosocial cancer care
Only eight countries (30%) reported having either published or nationally recommended clinical guidelines for PSOC.
Education, training resources and needs
In this dimension, it was asked if each country has the following: (i) communications skills training (CST) for healthcare professionals; (ii) CST provided during medical education; (iii) a post-graduate course or a master's degree in psycho-oncology; and (iv) an official certification for practising PSOC. Nineteen countries (70%) referred to having CST resources, and 17 countries (63%) provide CST during medical education; 17 (63%) mentioned having post-graduation courses in PSOC, but only nine (33%) have a Master of Science in this area. Only six countries (22%) reported having an official certification for PSOC. Training priorities in PSOC were also assessed in a number of areas, and data show that the most common priorities for the majority of countries were as follows: psychosocial intervention for patients and families (n = 19; 70%); management of distress (n = 18; 67%); communication skills for doctors and nurses (n = 18; 67%); and screening for distress/assessment of psychological morbidity (n = 16; 59%) (Figure 3) . 
Main difficulties, barriers or constraints to implementing psychosocial cancer care
At the end of the questionnaire, each participant was asked to comment on the main difficulties, barriers or constraints (if any) to implementing PSOC in their country. Seventeen (63%) countries added commentaries. The following is a list of the reported barriers to implementing PSOC:
• lack of budget and existing financial constraints impact availability of psychosocial resources; • lack of national standards and recommendations for clinical practice in psycho-oncology; • lack of investment in training and education for psycho-oncologists; • lack of investment in education of psycho-oncology care for medical staff; • lack of integration of psycho-oncology in multidisciplinary teams; • psychosocial healthcare providers working only part-time; • limited budget for outpatient psycho-oncological care;
• patients and healthcare providers are not well informed about the effects and supply of psychosocial care; • psychosocial care not integrated in cancer care management; • lack of an accreditation process for PSOC;
• lack of involvement of primary care psychosocial professionals in comprehensive cancer care; and • PSOC is not on the political/medical/health insurance companies' agendas in the same way as medical/nursing care (i.e. funding/reimbursement is only partial).
Discussion
This is the first EU study aimed at mapping resources and unmet training needs in PSOC and communication skills in Europe. The data generated by this study constitute an important benchmark against which to compare future progress towards expanding PSOC across Europe. Twenty-seven countries out of 30 represented in EPAAC, quite a representative sample of Europe particularly the EU, gave important information about the implementation of PSOC within their NHS. One main result is that the provision of psycho-oncology services in Europe is very diverse and irregular and greatly depends on whether or not a country and its NCCP or strategy regard PSOC as an important element of multidisciplinary cancer care. While there has been progress in the last years concerning inclusion of PSOC in the NCCPs by the majority of the EU countries [27] with most of them having included it, our data show that less than half of those have a budget for its provision. This evidence confirms that the majority of EU countries still struggle to have the financial capacity to implement a national psychosocial cancer policy. In fact, our results also show that the provision of PSOC is predominantly not within national or regional responsibility or financial budgets contrary to what the EU recommendation on NCCPs suggests [31] . Instead, it tends to be under local community or individual hospital responsibility, and in many cases, allocation of resources comes from charities' or non-governmental organization's budgets, thus leaving this important area of cancer care assigned to third parties, and their arbitrary and unregulated decision making regarding whether to support PSOC. There continues to be a lack of recognition that quality multidisciplinary cancer care requires the inclusion of specialist mental health professionals with too often medium-level to high-level PSOC services being left to under-trained and under-qualified voluntary and charitable sector staff. The consequence of this fact is a high variability in the provision of PSOC among and within EU countries and failure to provide safe, high-quality psycho-oncology services. This also fails to provide a good clinical governance structure and likely increases inequity of access to the services. Moreover, it is impossible to make sure that any audit or accreditation system to ensure quality standards for PSOC could be in place across EU countries. While the focus of this study was European healthcare services and the need to determine provision of PSOC, it is clear that the high variability is not a European-specific finding but has been reported in other parts of the world [25, 28] . Psychosocial care is more likely to be provided in a cancer centre or university hospital rather than in other smaller facilities that could be closer to the residence of patients, and mainly by psychologists and nurses who are the most likely professionals to deliver psychosocial care in most countries. The fact that there are very few countries reporting nationally recommended clinical guidelines for PSOC raises issues about disparities in the approach to care including potential differences in access to evidence-based treatments. Standardization of care and quality of service provision benefits from clinical guidelines, which ensure effective care, is delivered according to evidence-based practice standards for cancer patients. In fact, clinical guidelines aim to support clinical care providers to reduce inequities in care delivery and improve standards of care along with accountability across the different services in a country [27] , as there are already published clinical guidelines for psychosocial cancer care [32] , and they may be adopted by the countries that have still not developed their own.
In terms of education and training resources, the majority of the EU countries provide some post-graduate courses in PSOC and have training courses in communications skills for medical doctors; but only a few provide CST for healthcare professionals and have more formal accredited Master's of Science degrees and an official certification for PSOC. This highlights the frail nature and profile of specialists in psychosocial oncology in many of the European countries, which calls for better attention from societies and universities to invest in this area of education and specialization in health care. Also, not all the countries as yet have CST included in their medical education; neither do all have it available for regular training of healthcare professionals. As good communication skills with patients and families are an essential element for quality care [33] and the first level of psychosocial care [18, 19] , it would be crucial to increase the availability of CST as a mandatory part of all curricula for clinical practice, as has already been recommended [23] and is common practice in some countries [34] .
In relation to training priorities, it is recognized that improvement in training resources is needed in the majority of European countries and specific areas were identified, suggesting that actions are required to achieve this aim. However, this improvement seems to have evolved very slowly in the recent past. A study published 10 years ago [25] on the international differences in the psychosocial care of cancer patients in 38 countries worldwide, including many of the European countries that were included in our study, concluded that although psychosocial oncology began to be implemented during the 1980s or later in many countries, it was not fully integrated into cancer care in the majority of the countries and was not part of routine cancer care on a national scale. Moreover, this study identified different barriers to interdisciplinary cooperation, which were similar to the ones referred to in our study. Thus, in 10 years, the situation seems not to have changed much. We have indeed more NCCPs including PSOC recommendations, and we have some countries allocating budgets for this area; however, much remains to be changed and improved in daily practice by integrating PSOC in routine cancer care, and having more training, education and certification, and guidelines in PSOC. The recent European Guide for Quality National Cancer Control Programmes delivered by EPAAC has a chapter on psychosocial oncology [35] pointing out the required resources and direction to be followed by countries in this area to provide comprehensive quality cancer care, as well as the CANCON partnership programme (which has followed EPAAC) also launched with the strong involvement of many cancer plans from the European countries (www.cancercontrol.eu).
Study limitations
Although the questionnaire was easy to answer, it nevertheless required information and data that some officers did not have to hand in, which in some cases required assistance from experts in the field from their countries, who may not have been readily available. Also, EPAAC in the development of its deliverables from the various work packages required many surveys in different areas, namely, in cancer prevention, control, research and care from these Member States officers, which were timeconsuming and created delays in replying. Nevertheless, the 27 countries out of 30 that participated in this study are a very good percentage of adherence and representation of European countries. Other limitations relate to the pragmatic design of the questionnaire; to provide a good response rate, the survey was limited in focus, and as such, there is scope for further more-detailed research. The survey does not clarify whether the existence of a formal psychosocial oncology society leads to consultation at the governmental level, which includes these cancer professionals. Further research is needed to ascertain the impact of having a national PSOC society on these governmental consultation processes.
Conclusions and recommendations
We conclude from this survey that although many European countries seem to have integrated PSOC services into their NCCP, there is still a significant lag in implementing the delivery of quality comprehensive cancer care services, which include psychosocial care. There remains much to be done in terms of allocating limited resources and delivering the care equitably. Based on the research findings, recommendations include the following:
• develop national cancer policy and implementation of NCCPs by integrating PSOC services into routine cancer care as recommended by the European Guide for Quality National Cancer Control Programmes and ensure specific budgetary provisions for PSOC embedded in national cancer policy and NCCP; • ensure service providers and policymakers use existing PSOC clinical guidelines; • increase investment in training and education for psycho-oncologists and certification; • invest more in education on psycho-oncology care for medical staff as well as more investment in CST for healthcare professionals, including it as a part of all curricula for medical and clinical practice; • integrate psycho-oncology in multidisciplinary teams in cancer care; • promote accreditation processes for psychosocial care; and • provide adequate budget for outpatient psychooncological care and specific insurance funding/ reimbursement for psychosocial care.
Policymakers and service providers need to set targets for change that reduce inequity of access and improve professional standards for psychosocial care delivery in Europe. Extending the scope of provision so there is more involvement of primary care psychosocial professionals in comprehensive cancer care could improve patient access. Psycho-oncology professionals can help by engaging vigorously in discussion with cancer service providers. The EPAAC stresses the need for a paradigm shift in cancer care from disease-focused management to a patient-centred approach and highlights the importance of multidisciplinary teams for optimal coordination among professionals and communication with patients [35] .
At a minimum, it is hoped that the survey has raised awareness about the importance of psychosocial aspects of cancer within the Ministries of Health of the European countries that participated in this study. It is hoped that the results of this study, which was part of the report presented in 2014 as a deliverable by EPAAC to the European Commission and all European countries, will contribute to efforts to educate national and European policymakers about the importance of psycho-oncology in cancer care and guide their decisions for developing and improving their programmes and policies in this area. We hope that the initiatives conducted under the EPAAC will contribute to improvements in psychosocial cancer care in Europe, the success of which efforts should be evaluated in the future. Given clear evidence that PSOC benefits cancer patients across a number of outcome parameters, the EU cancer programme requires clear targets be set for delivering multidisciplinary quality cancer care equitably to patients, in line with the 2020 target for integrated cancer care across Europe.
